 | • レポートコード：GIR-107A15082 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、80ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、組換え凝固因子のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。組換え凝固因子の種類別市場規模（リコンビナントファクターVIII、リコンビナントファクターIX、フォンウィルブランドファクター）、用途別市場規模（病院、クリニック、研究機関）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・組換え凝固因子の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Baxter International Inc.、Bayer AG、Biogen Idec、CSL Ltd.、Grifols International SA、Kedrion S.P.A.、Novo Nordisk A/S、Octapharma AG、Pfizer Inc. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：リコンビナントファクターVIII、リコンビナントファクターIX、フォンウィルブランドファクター ・用途別分析2016年-2026年：病院、クリニック、研究機関 ・組換え凝固因子の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・組換え凝固因子のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・組換え凝固因子のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・組換え凝固因子の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・組換え凝固因子の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Recombinant Coagulation Factors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Recombinant Coagulation Factors size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Recombinant Coagulation Factors market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Recombinant Coagulation Factors market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Recombinant Factor VIII
Recombinant Factor IX
Von Willebrand Factor
Market segment by Application, can be divided into
Hospitals
Clinics
Research Organizations
Market segment by players, this report covers
Baxter International Inc.
Bayer AG
Biogen Idec
CSL Ltd.
Grifols International SA
Kedrion S.P.A.
Novo Nordisk A/S
Octapharma AG
Pfizer Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Recombinant Coagulation Factors product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Recombinant Coagulation Factors, with revenue, gross margin and global market share of Recombinant Coagulation Factors from 2019 to 2021.
Chapter 3, the Recombinant Coagulation Factors competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Recombinant Coagulation Factors market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Recombinant Coagulation Factors research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Recombinant Coagulation Factors
1.2 Classification of Recombinant Coagulation Factors by Type
1.2.1 Overview: Global Recombinant Coagulation Factors Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Recombinant Coagulation Factors Revenue Market Share by Type in 2020
1.2.3 Recombinant Factor VIII
1.2.4 Recombinant Factor IX
1.2.5 Von Willebrand Factor
1.3 Global Recombinant Coagulation Factors Market by Application
1.3.1 Overview: Global Recombinant Coagulation Factors Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Organizations
1.4 Global Recombinant Coagulation Factors Market Size & Forecast
1.5 Global Recombinant Coagulation Factors Market Size and Forecast by Region
1.5.1 Global Recombinant Coagulation Factors Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Recombinant Coagulation Factors Market Size by Region, (2016-2021)
1.5.3 North America Recombinant Coagulation Factors Market Size and Prospect (2016-2026)
1.5.4 Europe Recombinant Coagulation Factors Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Recombinant Coagulation Factors Market Size and Prospect (2016-2026)
1.5.6 South America Recombinant Coagulation Factors Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Recombinant Coagulation Factors Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Recombinant Coagulation Factors Market Drivers
1.6.2 Recombinant Coagulation Factors Market Restraints
1.6.3 Recombinant Coagulation Factors Trends Analysis
2 Company Profiles
2.1 Baxter International Inc.
2.1.1 Baxter International Inc. Details
2.1.2 Baxter International Inc. Major Business
2.1.3 Baxter International Inc. Recombinant Coagulation Factors Product and Solutions
2.1.4 Baxter International Inc. Recombinant Coagulation Factors Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Baxter International Inc. Recent Developments and Future Plans
2.2 Bayer AG
2.2.1 Bayer AG Details
2.2.2 Bayer AG Major Business
2.2.3 Bayer AG Recombinant Coagulation Factors Product and Solutions
2.2.4 Bayer AG Recombinant Coagulation Factors Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Bayer AG Recent Developments and Future Plans
2.3 Biogen Idec
2.3.1 Biogen Idec Details
2.3.2 Biogen Idec Major Business
2.3.3 Biogen Idec Recombinant Coagulation Factors Product and Solutions
2.3.4 Biogen Idec Recombinant Coagulation Factors Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Biogen Idec Recent Developments and Future Plans
2.4 CSL Ltd.
2.4.1 CSL Ltd. Details
2.4.2 CSL Ltd. Major Business
2.4.3 CSL Ltd. Recombinant Coagulation Factors Product and Solutions
2.4.4 CSL Ltd. Recombinant Coagulation Factors Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 CSL Ltd. Recent Developments and Future Plans
2.5 Grifols International SA
2.5.1 Grifols International SA Details
2.5.2 Grifols International SA Major Business
2.5.3 Grifols International SA Recombinant Coagulation Factors Product and Solutions
2.5.4 Grifols International SA Recombinant Coagulation Factors Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Grifols International SA Recent Developments and Future Plans
2.6 Kedrion S.P.A.
2.6.1 Kedrion S.P.A. Details
2.6.2 Kedrion S.P.A. Major Business
2.6.3 Kedrion S.P.A. Recombinant Coagulation Factors Product and Solutions
2.6.4 Kedrion S.P.A. Recombinant Coagulation Factors Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Kedrion S.P.A. Recent Developments and Future Plans
2.7 Novo Nordisk A/S
2.7.1 Novo Nordisk A/S Details
2.7.2 Novo Nordisk A/S Major Business
2.7.3 Novo Nordisk A/S Recombinant Coagulation Factors Product and Solutions
2.7.4 Novo Nordisk A/S Recombinant Coagulation Factors Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Novo Nordisk A/S Recent Developments and Future Plans
2.8 Octapharma AG
2.8.1 Octapharma AG Details
2.8.2 Octapharma AG Major Business
2.8.3 Octapharma AG Recombinant Coagulation Factors Product and Solutions
2.8.4 Octapharma AG Recombinant Coagulation Factors Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Octapharma AG Recent Developments and Future Plans
2.9 Pfizer Inc.
2.9.1 Pfizer Inc. Details
2.9.2 Pfizer Inc. Major Business
2.9.3 Pfizer Inc. Recombinant Coagulation Factors Product and Solutions
2.9.4 Pfizer Inc. Recombinant Coagulation Factors Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Pfizer Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Recombinant Coagulation Factors Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Recombinant Coagulation Factors Players Market Share
3.2.2 Top 10 Recombinant Coagulation Factors Players Market Share
3.2.3 Market Competition Trend
3.3 Recombinant Coagulation Factors Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Recombinant Coagulation Factors Revenue and Market Share by Type (2016-2021)
4.2 Global Recombinant Coagulation Factors Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Recombinant Coagulation Factors Revenue Market Share by Application (2016-2021)
5.2 Recombinant Coagulation Factors Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Recombinant Coagulation Factors Revenue by Type (2016-2026)
6.2 North America Recombinant Coagulation Factors Revenue by Application (2016-2026)
6.3 North America Recombinant Coagulation Factors Market Size by Country
6.3.1 North America Recombinant Coagulation Factors Revenue by Country (2016-2026)
6.3.2 United States Recombinant Coagulation Factors Market Size and Forecast (2016-2026)
6.3.3 Canada Recombinant Coagulation Factors Market Size and Forecast (2016-2026)
6.3.4 Mexico Recombinant Coagulation Factors Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Recombinant Coagulation Factors Revenue by Type (2016-2026)
7.2 Europe Recombinant Coagulation Factors Revenue by Application (2016-2026)
7.3 Europe Recombinant Coagulation Factors Market Size by Country
7.3.1 Europe Recombinant Coagulation Factors Revenue by Country (2016-2026)
7.3.2 Germany Recombinant Coagulation Factors Market Size and Forecast (2016-2026)
7.3.3 France Recombinant Coagulation Factors Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Recombinant Coagulation Factors Market Size and Forecast (2016-2026)
7.3.5 Russia Recombinant Coagulation Factors Market Size and Forecast (2016-2026)
7.3.6 Italy Recombinant Coagulation Factors Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Recombinant Coagulation Factors Revenue by Type (2016-2026)
8.2 Asia-Pacific Recombinant Coagulation Factors Revenue by Application (2016-2026)
8.3 Asia-Pacific Recombinant Coagulation Factors Market Size by Region
8.3.1 Asia-Pacific Recombinant Coagulation Factors Revenue by Region (2016-2026)
8.3.2 China Recombinant Coagulation Factors Market Size and Forecast (2016-2026)
8.3.3 Japan Recombinant Coagulation Factors Market Size and Forecast (2016-2026)
8.3.4 South Korea Recombinant Coagulation Factors Market Size and Forecast (2016-2026)
8.3.5 India Recombinant Coagulation Factors Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Recombinant Coagulation Factors Market Size and Forecast (2016-2026)
8.3.7 Australia Recombinant Coagulation Factors Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Recombinant Coagulation Factors Revenue by Type (2016-2026)
9.2 South America Recombinant Coagulation Factors Revenue by Application (2016-2026)
9.3 South America Recombinant Coagulation Factors Market Size by Country
9.3.1 South America Recombinant Coagulation Factors Revenue by Country (2016-2026)
9.3.2 Brazil Recombinant Coagulation Factors Market Size and Forecast (2016-2026)
9.3.3 Argentina Recombinant Coagulation Factors Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Recombinant Coagulation Factors Revenue by Type (2016-2026)
10.2 Middle East & Africa Recombinant Coagulation Factors Revenue by Application (2016-2026)
10.3 Middle East & Africa Recombinant Coagulation Factors Market Size by Country
10.3.1 Middle East & Africa Recombinant Coagulation Factors Revenue by Country (2016-2026)
10.3.2 Turkey Recombinant Coagulation Factors Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Recombinant Coagulation Factors Market Size and Forecast (2016-2026)
10.3.4 UAE Recombinant Coagulation Factors Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Recombinant Coagulation Factors Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Recombinant Coagulation Factors Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Recombinant Coagulation Factors Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Recombinant Coagulation Factors Revenue (USD Million) by Region (2016-2021)
Table 5. Global Recombinant Coagulation Factors Revenue Market Share by Region (2021-2026)
Table 6. Baxter International Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Baxter International Inc. Major Business
Table 8. Baxter International Inc. Recombinant Coagulation Factors Product and Solutions
Table 9. Baxter International Inc. Recombinant Coagulation Factors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Bayer AG Corporate Information, Head Office, and Major Competitors
Table 11. Bayer AG Major Business
Table 12. Bayer AG Recombinant Coagulation Factors Product and Solutions
Table 13. Bayer AG Recombinant Coagulation Factors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Biogen Idec Corporate Information, Head Office, and Major Competitors
Table 15. Biogen Idec Major Business
Table 16. Biogen Idec Recombinant Coagulation Factors Product and Solutions
Table 17. Biogen Idec Recombinant Coagulation Factors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. CSL Ltd. Corporate Information, Head Office, and Major Competitors
Table 19. CSL Ltd. Major Business
Table 20. CSL Ltd. Recombinant Coagulation Factors Product and Solutions
Table 21. CSL Ltd. Recombinant Coagulation Factors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Grifols International SA Corporate Information, Head Office, and Major Competitors
Table 23. Grifols International SA Major Business
Table 24. Grifols International SA Recombinant Coagulation Factors Product and Solutions
Table 25. Grifols International SA Recombinant Coagulation Factors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Kedrion S.P.A. Corporate Information, Head Office, and Major Competitors
Table 27. Kedrion S.P.A. Major Business
Table 28. Kedrion S.P.A. Recombinant Coagulation Factors Product and Solutions
Table 29. Kedrion S.P.A. Recombinant Coagulation Factors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Novo Nordisk A/S Corporate Information, Head Office, and Major Competitors
Table 31. Novo Nordisk A/S Major Business
Table 32. Novo Nordisk A/S Recombinant Coagulation Factors Product and Solutions
Table 33. Novo Nordisk A/S Recombinant Coagulation Factors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Octapharma AG Corporate Information, Head Office, and Major Competitors
Table 35. Octapharma AG Major Business
Table 36. Octapharma AG Recombinant Coagulation Factors Product and Solutions
Table 37. Octapharma AG Recombinant Coagulation Factors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Pfizer Inc. Corporate Information, Head Office, and Major Competitors
Table 39. Pfizer Inc. Major Business
Table 40. Pfizer Inc. Recombinant Coagulation Factors Product and Solutions
Table 41. Pfizer Inc. Recombinant Coagulation Factors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global Recombinant Coagulation Factors Revenue (USD Million) by Players (2019-2021)
Table 43. Global Recombinant Coagulation Factors Revenue Share by Players (2019-2021)
Table 44. Breakdown of Recombinant Coagulation Factors by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Recombinant Coagulation Factors Players Head Office, Products and Services Provided
Table 46. Recombinant Coagulation Factors Mergers & Acquisitions in the Past Five Years
Table 47. Recombinant Coagulation Factors New Entrants and Expansion Plans
Table 48. Global Recombinant Coagulation Factors Revenue (USD Million) by Type (2016-2021)
Table 49. Global Recombinant Coagulation Factors Revenue Share by Type (2016-2021)
Table 50. Global Recombinant Coagulation Factors Revenue Forecast by Type (2021-2026)
Table 51. Global Recombinant Coagulation Factors Revenue by Application (2016-2021)
Table 52. Global Recombinant Coagulation Factors Revenue Forecast by Application (2021-2026)
Table 53. North America Recombinant Coagulation Factors Revenue by Type (2016-2021) & (USD Million)
Table 54. North America Recombinant Coagulation Factors Revenue by Type (2021-2026) & (USD Million)
Table 55. North America Recombinant Coagulation Factors Revenue by Application (2016-2021) & (USD Million)
Table 56. North America Recombinant Coagulation Factors Revenue by Application (2021-2026) & (USD Million)
Table 57. North America Recombinant Coagulation Factors Revenue by Country (2016-2021) & (USD Million)
Table 58. North America Recombinant Coagulation Factors Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe Recombinant Coagulation Factors Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe Recombinant Coagulation Factors Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe Recombinant Coagulation Factors Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe Recombinant Coagulation Factors Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe Recombinant Coagulation Factors Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe Recombinant Coagulation Factors Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific Recombinant Coagulation Factors Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific Recombinant Coagulation Factors Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific Recombinant Coagulation Factors Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific Recombinant Coagulation Factors Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific Recombinant Coagulation Factors Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific Recombinant Coagulation Factors Revenue by Region (2021-2026) & (USD Million)
Table 71. South America Recombinant Coagulation Factors Revenue by Type (2016-2021) & (USD Million)
Table 72. South America Recombinant Coagulation Factors Revenue by Type (2021-2026) & (USD Million)
Table 73. South America Recombinant Coagulation Factors Revenue by Application (2016-2021) & (USD Million)
Table 74. South America Recombinant Coagulation Factors Revenue by Application (2021-2026) & (USD Million)
Table 75. South America Recombinant Coagulation Factors Revenue by Country (2016-2021) & (USD Million)
Table 76. South America Recombinant Coagulation Factors Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa Recombinant Coagulation Factors Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa Recombinant Coagulation Factors Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa Recombinant Coagulation Factors Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa Recombinant Coagulation Factors Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa Recombinant Coagulation Factors Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa Recombinant Coagulation Factors Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Recombinant Coagulation Factors Picture
Figure 2. Global Recombinant Coagulation Factors Revenue Market Share by Type in 2020
Figure 3. Recombinant Factor VIII
Figure 4. Recombinant Factor IX
Figure 5. Von Willebrand Factor
Figure 6. Recombinant Coagulation Factors Revenue Market Share by Application in 2020
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Research Organizations Picture
Figure 10. Global Recombinant Coagulation Factors Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Recombinant Coagulation Factors Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Recombinant Coagulation Factors Revenue Market Share by Region (2016-2026)
Figure 13. Global Recombinant Coagulation Factors Revenue Market Share by Region in 2020
Figure 14. North America Recombinant Coagulation Factors Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Recombinant Coagulation Factors Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Recombinant Coagulation Factors Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Recombinant Coagulation Factors Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Recombinant Coagulation Factors Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Recombinant Coagulation Factors Market Drivers
Figure 20. Recombinant Coagulation Factors Market Restraints
Figure 21. Recombinant Coagulation Factors Market Trends
Figure 22. Baxter International Inc. Recent Developments and Future Plans
Figure 23. Bayer AG Recent Developments and Future Plans
Figure 24. Biogen Idec Recent Developments and Future Plans
Figure 25. CSL Ltd. Recent Developments and Future Plans
Figure 26. Grifols International SA Recent Developments and Future Plans
Figure 27. Kedrion S.P.A. Recent Developments and Future Plans
Figure 28. Novo Nordisk A/S Recent Developments and Future Plans
Figure 29. Octapharma AG Recent Developments and Future Plans
Figure 30. Pfizer Inc. Recent Developments and Future Plans
Figure 31. Global Recombinant Coagulation Factors Revenue Share by Players in 2020
Figure 32. Recombinant Coagulation Factors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 33. Global Top 3 Players Recombinant Coagulation Factors Revenue Market Share in 2020
Figure 34. Global Top 10 Players Recombinant Coagulation Factors Revenue Market Share in 2020
Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 36. Global Recombinant Coagulation Factors Revenue Share by Type in 2020
Figure 37. Global Recombinant Coagulation Factors Market Share Forecast by Type (2021-2026)
Figure 38. Global Recombinant Coagulation Factors Revenue Share by Application in 2020
Figure 39. Global Recombinant Coagulation Factors Market Share Forecast by Application (2021-2026)
Figure 40. North America Recombinant Coagulation Factors Sales Market Share by Type (2016-2026)
Figure 41. North America Recombinant Coagulation Factors Sales Market Share by Application (2016-2026)
Figure 42. North America Recombinant Coagulation Factors Revenue Market Share by Country (2016-2026)
Figure 43. United States Recombinant Coagulation Factors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Recombinant Coagulation Factors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Recombinant Coagulation Factors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Recombinant Coagulation Factors Sales Market Share by Type (2016-2026)
Figure 47. Europe Recombinant Coagulation Factors Sales Market Share by Application (2016-2026)
Figure 48. Europe Recombinant Coagulation Factors Revenue Market Share by Country (2016-2026)
Figure 49. Germany Recombinant Coagulation Factors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Recombinant Coagulation Factors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Recombinant Coagulation Factors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Recombinant Coagulation Factors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Recombinant Coagulation Factors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Recombinant Coagulation Factors Sales Market Share by Type (2016-2026)
Figure 55. Asia-Pacific Recombinant Coagulation Factors Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Recombinant Coagulation Factors Revenue Market Share by Region (2016-2026)
Figure 57. China Recombinant Coagulation Factors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Recombinant Coagulation Factors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South Korea Recombinant Coagulation Factors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Recombinant Coagulation Factors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Recombinant Coagulation Factors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Recombinant Coagulation Factors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Recombinant Coagulation Factors Sales Market Share by Type (2016-2026)
Figure 64. South America Recombinant Coagulation Factors Sales Market Share by Application (2016-2026)
Figure 65. South America Recombinant Coagulation Factors Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Recombinant Coagulation Factors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Recombinant Coagulation Factors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East and Africa Recombinant Coagulation Factors Sales Market Share by Type (2016-2026)
Figure 69. Middle East and Africa Recombinant Coagulation Factors Sales Market Share by Application (2016-2026)
Figure 70. Middle East and Africa Recombinant Coagulation Factors Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Recombinant Coagulation Factors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Saudi Arabia Recombinant Coagulation Factors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. UAE Recombinant Coagulation Factors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Methodology
Figure 75. Research Process and Data Source
世界のフォン・ヴィレブランド因子（組換え）市場 2021：企業別、地域別、種類・用途別 The von Willebrand Factor (Recombinant) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…- 世界の凝固因子IX市場 2021：企業別、地域別、種類・用途別 The Coagulation Factor IX market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 世界の抗血友病因子（組換え）市場インサイト2021：企業別、地域別、種類別、用途別 This report describes the global market size of Antihemophilic Factor (Recombinant) from 2016 to 2020 and its CAGR from 2016 to 2020, and also forecasts its market size to the end of 2026 and its CAGR from 2021 to 2026. For geography segment, regional supply, demand, major players, price is presente…
- 世界の凝固因子XI市場 2021：企業別、地域別、種類・用途別 The Coagulation Factor XI market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 世界の遺伝子組換え型血漿タンパク質治療薬市場 2021：企業別、地域別、種類・用途別 The Recombinant Plasma Protein Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…